Fore Capital, LLC
- SEC CIK
- 0001714672
- Latest filing
- Aug 10, 2026
DFTX holding history
Definium Therapeutics, Inc. in every 13F filed by Fore Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 20,000
- Value
- $940.8K
- % of portfolio
- 1.2%
- Quarters held
- 12
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 20,000 | $940.8K | 1.2% | +20,000 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −15,000−100.0% | Sold out | Holders |
| Q4 2025 | 15,000 | $200.8K | 0.3% | −20,000−57.1% | Reduced | Holders |
| Q3 2025 | 35,000 | $412.6K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2025 | 35,000 | $227.2K | 0.5% | −5,000−12.5% | Reduced | Holders |
| Q1 2025 | 40,000 | $234.0K | 0.3% | +2,461+6.6% | Added | Holders |
| Q4 2024 | 37,539 | $261.3K | 0.3% | +7,539+25.1% | Added | Holders |
| Q3 2024 | 30,000 | $170.7K | 0.3% | +15,000+100.0% | Added | Holders |
| Q2 2024 | 15,000 | $108.2K | 0.2% | +15,000 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −47,999−100.0% | Sold out | Holders |
| Q4 2022 | 47,999 | $105.6K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2022 | 47,999 | $168.0K | 0.6% | +37,332+350.0% | AddedConverted for a 1-for-15 split | Holders |
| Q2 2022 | 160,000 | $102.0K | 0.3% | +60,000+60.0% | Added | Holders |
| Q1 2022 | 100,000 | $111.0K | 0.1% | +100,000 | New | Holders |